Oklo and Centrus Explore Joint Venture for HALEU Services
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 18 hours ago
0mins
Should l Buy OKLO?
Source: Benzinga
- Joint Venture Exploration: Oklo Inc. and Centrus Energy Corp. announced plans to explore a joint venture for high-assay low-enriched uranium (HALEU) deconversion services at Centrus' Piketon site in Ohio, aiming to enhance efficiency and reduce costs through integrated uranium enrichment and deconversion processes.
- Nuclear Supply Chain Rebuilding: Oklo CEO Jacob DeWitte emphasized that advanced nuclear energy development requires not only reactors but also reliable fuel-cycle capabilities, highlighting the importance of rebuilding the U.S. nuclear fuel supply chain to meet growing demands.
- Technical Analysis Signals: Oklo's stock is currently trading 11.5% below its 20-day SMA and 38.6% below its 100-day SMA, indicating a bearish trend in the medium term; however, the MACD shows potential upward momentum, suggesting mixed market sentiment.
- Analyst Ratings and Outlook: Oklo's stock carries a Buy rating with an average price target of $110.88, and despite recent target downgrades by analysts, the overall strong market performance indicates investor confidence in its future prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OKLO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OKLO
Wall Street analysts forecast OKLO stock price to rise
12 Analyst Rating
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 58.250
Low
90.00
Averages
125.11
High
175.00
Current: 58.250
Low
90.00
Averages
125.11
High
175.00
About OKLO
Oklo Inc. is an advanced nuclear technology company. The Company is engaged in developing fast fission power plants to provide clean, reliable, and affordable energy at scale. It is developing advanced fuel recycling technologies in collaboration with the United States Department of Energy and United States National Laboratories. It provides 24/7 clean energy to data centers, factories, industrial sites, communities, and defense facilities. It offers heat and power through power purchase agreements. Its powerhouse product line, Aurora, is designed to be inherently safe, to be able to run on fresh or recycled fuel, and to produce 15-50 megawatts electric (MWe) and with the potential to expand powerhouse size to produce 100 MWe of electricity. The Company intends to develop specialized radioisotope production capabilities to address urgent supply shortages in life-saving medical radioisotopes and advanced industrial applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oklo Faces Nuclear Licensing Challenges Amid AI Demand
- Customer Backing Importance: Oklo's ability to secure new customer support is crucial as it navigates the surge in AI-driven power demand, which not only strengthens its market position but also lays the groundwork for future growth.
- Execution Risk Analysis: While Oklo possesses technological potential, the execution risks associated with the nuclear licensing process remain, which could impact project timelines and investor confidence.
- Long-Term Growth Potential: The company's long-term growth hinges on achieving key milestones that most investors have yet to fully price in, indicating that potential investment opportunities may be undervalued.
- Market Reaction Lag: Market prices as of March 2, 2026, indicate a lag in investor response to Oklo's future prospects, which could lead to short-term stock price volatility and affect the company's financing capabilities.
See More
Oklo and Centrus Explore Joint Venture for HALEU Services
- Joint Venture Exploration: Oklo Inc. and Centrus Energy Corp. announced plans to explore a joint venture for high-assay low-enriched uranium (HALEU) deconversion services at Centrus' Piketon site in Ohio, aiming to enhance efficiency and reduce costs through integrated uranium enrichment and deconversion processes.
- Nuclear Supply Chain Rebuilding: Oklo CEO Jacob DeWitte emphasized that advanced nuclear energy development requires not only reactors but also reliable fuel-cycle capabilities, highlighting the importance of rebuilding the U.S. nuclear fuel supply chain to meet growing demands.
- Technical Analysis Signals: Oklo's stock is currently trading 11.5% below its 20-day SMA and 38.6% below its 100-day SMA, indicating a bearish trend in the medium term; however, the MACD shows potential upward momentum, suggesting mixed market sentiment.
- Analyst Ratings and Outlook: Oklo's stock carries a Buy rating with an average price target of $110.88, and despite recent target downgrades by analysts, the overall strong market performance indicates investor confidence in its future prospects.
See More
Oklo and Centrus Energy to Form Joint Venture for Uranium Services
- Joint Venture Development: Oklo and Centrus Energy announced plans to explore the creation of a joint venture at Centrus' Piketon site in Ohio, focusing on deconversion services for high-assay low-enriched uranium, aiming to enhance efficiency and reduce costs through co-location.
- Domestic Nuclear Capacity Expansion: The joint venture is strategically positioned next to Centrus' enrichment operations, intending to integrate uranium enrichment and deconversion services to expand domestic advanced nuclear fuel production capacity and address potential bottlenecks in large-scale nuclear technology deployment.
- Technological and Supply Chain Advancements: Developing enrichment and deconversion services at the Piketon location is expected to improve overall efficiency and strengthen the stability of the domestic nuclear fuel supply chain, supporting the rapid advancement of nuclear technology.
- Strategic Collaboration Significance: This partnership not only aims to resolve nuclear fuel supply bottlenecks but also enhances the long-term strategic positioning of both companies in the nuclear energy sector, thereby increasing their market competitiveness.
See More
Oklo Faces Nuclear Licensing Challenges Amid AI Demand
- Importance of Customer Backing: Oklo is navigating the tension between explosive AI-driven power demand and the slow reality of nuclear licensing, making customer support crucial for its future growth, especially as demand for nuclear energy increases.
- Execution Risk Assessment: While Oklo has technological potential, it faces execution risks that could impact its competitiveness in the nuclear market, particularly given the slow regulatory approval process, necessitating cautious evaluation from investors.
- Long-Term Growth Potential: Oklo's long-term growth hinges on achieving key milestones that most investors are not yet fully pricing in, indicating a potential underestimation of its future prospects in the market.
- Investor Focus: Despite Oklo's innovations in nuclear energy, analyst teams have identified 10 stocks as better investment choices, with Oklo not making the list, reflecting a cautious market sentiment regarding its future performance.
See More
NuScale and Oklo Compete to Disrupt Nuclear Energy Market
- Market Competition: Both NuScale and Oklo aim to disrupt the nuclear energy market with small modular reactors (SMRs) and microreactors, with NuScale's stock plummeting nearly 80% since last year while Oklo's has only declined 20%, indicating differing market expectations for the two companies.
- Technological Advantages: NuScale's SMR design has received Standard Design Approval from the U.S. Nuclear Regulatory Commission and is set to be used in a 462 MWe plant in Romania, while Oklo's microreactors start at 1.5 MWe, offering greater flexibility for deployment in remote areas.
- Revenue Outlook: Analysts expect NuScale's revenue to rise from $31 million to $287 million between 2025 and 2028, despite its first reactors not coming online until the early 2030s, while Oklo anticipates generating $16 million in revenue in 2027, highlighting the differences in their growth trajectories.
- Valuation Analysis: Oklo's market cap stands at $9.7 billion, trading at over 600 times its projected 2027 sales, while NuScale's market cap is $3.9 billion, with a more reasonable valuation at 19 times its 2027 sales, reflecting the market's differing valuation strategies for the two firms.
See More
NuScale and Oklo Compete in Nuclear Energy Market
- Market Outlook: NuScale's upcoming nuclear plants in Romania and the U.S. could significantly boost sales, yet its stock has plunged nearly 80% since last year, indicating market concerns about its future growth potential.
- Technological Comparison: Oklo's microreactors offer greater flexibility for remote deployments and utilize cheaper metallic uranium fuel pellets, with expectations to generate $16 million in revenue by 2027, showcasing its competitive edge in the small nuclear market.
- Revenue Forecast Discrepancy: Analysts predict NuScale's revenue will rise from $31 million in 2025 to $287 million by 2028, although its first reactors won't come online until the early 2030s, indicating a reliance on front-end engineering for short-term income.
- Valuation Comparison: Oklo's market cap stands at $9.7 billion with projected sales over 600 times for 2027, while NuScale's market cap is $3.9 billion with a more attractive 19 times valuation for 2027 sales, highlighting the challenges both companies face in maintaining investor interest.
See More
Oklo Faces Nuclear Licensing Challenges Amid AI Demand
- Customer Backing Importance: Oklo's ability to secure new customer support is crucial as it navigates the surge in AI-driven power demand, which not only strengthens its market position but also lays the groundwork for future growth.
- Execution Risk Analysis: While Oklo possesses technological potential, the execution risks associated with the nuclear licensing process remain, which could impact project timelines and investor confidence.
- Long-Term Growth Potential: The company's long-term growth hinges on achieving key milestones that most investors have yet to fully price in, indicating that potential investment opportunities may be undervalued.
- Market Reaction Lag: Market prices as of March 2, 2026, indicate a lag in investor response to Oklo's future prospects, which could lead to short-term stock price volatility and affect the company's financing capabilities.
See More
Oklo and Centrus Explore Joint Venture for HALEU Services
- Joint Venture Exploration: Oklo Inc. and Centrus Energy Corp. announced plans to explore a joint venture for high-assay low-enriched uranium (HALEU) deconversion services at Centrus' Piketon site in Ohio, aiming to enhance efficiency and reduce costs through integrated uranium enrichment and deconversion processes.
- Nuclear Supply Chain Rebuilding: Oklo CEO Jacob DeWitte emphasized that advanced nuclear energy development requires not only reactors but also reliable fuel-cycle capabilities, highlighting the importance of rebuilding the U.S. nuclear fuel supply chain to meet growing demands.
- Technical Analysis Signals: Oklo's stock is currently trading 11.5% below its 20-day SMA and 38.6% below its 100-day SMA, indicating a bearish trend in the medium term; however, the MACD shows potential upward momentum, suggesting mixed market sentiment.
- Analyst Ratings and Outlook: Oklo's stock carries a Buy rating with an average price target of $110.88, and despite recent target downgrades by analysts, the overall strong market performance indicates investor confidence in its future prospects.
See More
Oklo and Centrus Energy to Form Joint Venture for Uranium Services
- Joint Venture Development: Oklo and Centrus Energy announced plans to explore the creation of a joint venture at Centrus' Piketon site in Ohio, focusing on deconversion services for high-assay low-enriched uranium, aiming to enhance efficiency and reduce costs through co-location.
- Domestic Nuclear Capacity Expansion: The joint venture is strategically positioned next to Centrus' enrichment operations, intending to integrate uranium enrichment and deconversion services to expand domestic advanced nuclear fuel production capacity and address potential bottlenecks in large-scale nuclear technology deployment.
- Technological and Supply Chain Advancements: Developing enrichment and deconversion services at the Piketon location is expected to improve overall efficiency and strengthen the stability of the domestic nuclear fuel supply chain, supporting the rapid advancement of nuclear technology.
- Strategic Collaboration Significance: This partnership not only aims to resolve nuclear fuel supply bottlenecks but also enhances the long-term strategic positioning of both companies in the nuclear energy sector, thereby increasing their market competitiveness.
See More
Oklo Faces Nuclear Licensing Challenges Amid AI Demand
- Importance of Customer Backing: Oklo is navigating the tension between explosive AI-driven power demand and the slow reality of nuclear licensing, making customer support crucial for its future growth, especially as demand for nuclear energy increases.
- Execution Risk Assessment: While Oklo has technological potential, it faces execution risks that could impact its competitiveness in the nuclear market, particularly given the slow regulatory approval process, necessitating cautious evaluation from investors.
- Long-Term Growth Potential: Oklo's long-term growth hinges on achieving key milestones that most investors are not yet fully pricing in, indicating a potential underestimation of its future prospects in the market.
- Investor Focus: Despite Oklo's innovations in nuclear energy, analyst teams have identified 10 stocks as better investment choices, with Oklo not making the list, reflecting a cautious market sentiment regarding its future performance.
See More
NuScale and Oklo Compete to Disrupt Nuclear Energy Market
- Market Competition: Both NuScale and Oklo aim to disrupt the nuclear energy market with small modular reactors (SMRs) and microreactors, with NuScale's stock plummeting nearly 80% since last year while Oklo's has only declined 20%, indicating differing market expectations for the two companies.
- Technological Advantages: NuScale's SMR design has received Standard Design Approval from the U.S. Nuclear Regulatory Commission and is set to be used in a 462 MWe plant in Romania, while Oklo's microreactors start at 1.5 MWe, offering greater flexibility for deployment in remote areas.
- Revenue Outlook: Analysts expect NuScale's revenue to rise from $31 million to $287 million between 2025 and 2028, despite its first reactors not coming online until the early 2030s, while Oklo anticipates generating $16 million in revenue in 2027, highlighting the differences in their growth trajectories.
- Valuation Analysis: Oklo's market cap stands at $9.7 billion, trading at over 600 times its projected 2027 sales, while NuScale's market cap is $3.9 billion, with a more reasonable valuation at 19 times its 2027 sales, reflecting the market's differing valuation strategies for the two firms.
See More
NuScale and Oklo Compete in Nuclear Energy Market
- Market Outlook: NuScale's upcoming nuclear plants in Romania and the U.S. could significantly boost sales, yet its stock has plunged nearly 80% since last year, indicating market concerns about its future growth potential.
- Technological Comparison: Oklo's microreactors offer greater flexibility for remote deployments and utilize cheaper metallic uranium fuel pellets, with expectations to generate $16 million in revenue by 2027, showcasing its competitive edge in the small nuclear market.
- Revenue Forecast Discrepancy: Analysts predict NuScale's revenue will rise from $31 million in 2025 to $287 million by 2028, although its first reactors won't come online until the early 2030s, indicating a reliance on front-end engineering for short-term income.
- Valuation Comparison: Oklo's market cap stands at $9.7 billion with projected sales over 600 times for 2027, while NuScale's market cap is $3.9 billion with a more attractive 19 times valuation for 2027 sales, highlighting the challenges both companies face in maintaining investor interest.
See More
